John Parkinson, CPA, CA, B.Comm, B.A.

Chief Financial Officer

Mr. Parkinson has extensive senior level experience in leadership of companies in a number of industry sectors. Mr. Parkinson is the President of Helmsman Management Ltd., a company providing executive and asset management services to enterprises in a number of sectors. Immediately prior to establishing Helmsman, Mr. Parkinson was the Chief Executive Officer of a diverse group of investment funds. Previous roles include Chief Financial Officer of Protox Therapeutics Inc., a TSX listed bio-technology company and, prior to that, Vice President, Finance at Aspreva Pharmaceuticals, a NASDAQ & TSX dual-listed pharmaceutical company. Prior to his role with Aspreva, Mr. Parkinson focused on financial, high-tech and public company practices during his 10 years with KPMG in both the United Kingdom and Canada. Mr. Parkinson holds Bachelor of Commerce and Bachelor of Arts in Economics degrees from the University of Saskatchewan, Saskatoon, Canada. Mr. Parkinson achieved his designation as a Chartered Accountant from the Institute of Chartered Accountants of British Columbia in 1995.

Vitaeris is now part of CSL Behring! We are pleased to become part of CSL Behring, a well-established, global industry leader, and know that the future of clazakizumab is in excellent hands. Together, we have already achieved much progress through our partnership over the past few years and are now in an even stronger position to realize our collective goal of addressing one of the greatest unmet needs in the organ transplant community.

Learn more